Lysergic Acid Diethylamide
Drug class: Psychedelic
Other names: L, Acid, Lucy, Tabs
Onset of action: 30-40 minutes
Peak: 8-20 hours
LSD (lysergic acid diethylamide) is a semi-synthetic compound first developed in 1938 by Dr. Albert Hofmann at the Sandoz pharmaceutical company in Basel, Switzerland. After Dr. Hofmann first discovered its effects in 1943, LSD quickly became recognized for its possible therapeutic effects. LSD also played a significant role in the discovery of the serotonin neurotransmitter system.
Did you know?
- From the 1950s through the early 1970s, psychiatrists, therapists, and researchers administered LSD to thousands of people.
- LSD is known for its ability to catalyze spiritual or mystical experiences and to facilitate feelings of interconnection.
- MAPS-sponsored study results indicate that LSD-assisted therapy can be safely administered and justifies further research.
See what’s happening in today’s LSD news.
Red Table Talk with the Smith Family: The Miracle Treatment We Almost Couldn’t Tell You About
November 10, 2021
Summary: On a new episode of Red Table Talk, Jaden Smith, Jada Pinkett Smith, and Gammy Norris speak with author Michael Pollan, journalist Lisa Ling, oncologist Paul Song, and entrepreneur Bob Parsons …
WIRED: Big Tech’s Psychedelics Grift
November 7, 2021
Summary: WIRED investigates the growth of support for psychedelic medicine, highlighting how entrepreneurs from the technology industry are contributing to the field through philanthropic contributions …
NBC News NOW: Could Mushrooms, Molly and Acid Be the New Wave of Mental Health Care?
October 13, 2021
“The best way to create access right now is to go through the drug development process and have [psychedelic-assisted therapies] approved by the FDA,” Amy Emerson, CEO of MAPS Public Benefit …
WIRED: The Case for Using MDMA to Help Heal Victims of Trauma
May 18, 2021
Summary; “In the 30 years since the pharmaceutical revolution began, psychiatry may be the only medical field to lose ground to its diseases,” says Scott Shannon, M.D. “Until MDMA, perhaps.” …
Time Magazine: A New Study Points to MDMA as a Powerful Treatment for PTSD
May 11, 2021
The findings were powerful enough that Mitchell believes they not only could mean that MDMA will become a frontline treatment for PTSD, but that similar drugs could emerge with their own therapeutic value. …
Real Sports with Bryant Gumbel: Psychedelics in Sports
December 3, 2020
Summary: Watch the full segment “Psychedelics in Sports” of the HBO Max series Real Sports with Bryant Gumbel in which MAPS Founder and Executive Director Rick Doblin, Ph.D., and psychedelic …
Peter Attia Podcast: Rick Doblin, PH.D.: MDMA — The Creation, Scheduling, Toxicity, Therapeutic Use, and Changing Public Opinion of What is Possibly the Single Most Important Synthetic Molecule Ever Created by Our Species
August 5, 2019
Summary: MAPS Founder Rick Doblin, Ph.D., shares insights he learned from over 30 years of working to change public opinion and policy around psychedelics, and explores the history, clinical data, and …
Inside Eyes Podcast: Ismail Ali and Jag Davies on Entheogens & Psychedelics – Legalization, Decriminalization, & Medicalization
August 5, 2019
Summary: Inside Eyes Podcast interviews Ismail Ali, J.D., of MAPS and drug policy expert Jag Davies about psychedelic medicine. In this episode, they explore answers around access to psychedelic therapy …
MAPS Podcast: Episode 39 – James Oroc: The New Psychedelic Revolution
April 4, 2019
Originally appearing here. In this episode of the MAPS Podcast, James Oroc, journalist, photographer, and artist, offers his insights, opinions and experiences on topics ranging from 5-MEO DMT, the re-birth …
CBC Radio: Why Some Investors and Medical Researchers Are Looking Past Pot to Psychedelic Drugs (Podcast)
September 9, 2018
Summary: CBC Radio highlights the therapeutic use of psychedelics in a new series, exploring how the shifting public perception and rise of acceptance is influencing an increase in financial support for …
Sounds True: Rick Doblin: The Psychedelic Renaissance (Podcast)
July 31, 2018
Summary: MAPS Founder Rick Doblin, Ph.D., speaks to Sounds True about the progress of MDMA-assisted psychotherapy for PTSD in clinical research contexts, and shares personal experiences that led to his …
MAPS Podcast: Episode 28 – Lex Pelger: The Inner Workings of a Drug Writer
April 24, 2018
Originally appearing here. The inner workings of a drug writer as he shares his perspective, spirit and mind. Lex Pelger – the blazingly prolific writer, podcaster, traveling salon MC and psychedelic …